ArticleAntimicrobial agents and chemotherapy2025

Cefepime-taniborbactam and ceftibuten-ledaborbactam maintain activity against KPC variants that lead to ceftazidime-avibactam resistance.

Cullen L Myers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.